Confirmed Speakers


Catherine Alix-Panabières
, PhD
Laboratoire Cellules Circulantes Rares Humaines - LCCRH, Institut de Recherche en Biothérapie - IRB, Hôpital Saint-Eloi - CHRU Montpellier, France

Emmanuel Antonarakis
, MD
Associate Director for Translational Research and Director of Genitourinary Oncology in HOT Division, University of Minnesota–Masonic Cancer Center, USA

Alberto Bardelli
Professor, Department of Oncology, University of Torino, Candiolo, Italy

Ryan Corcoran, MD
Assoc. Professor, Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, Massachusetts



Richard J. Cote
, M.D. FRCPath, FCAP
Professor and Incoming Chair, Department of Pathology and Immunology, Pathologist-in-Chief, Barnes-Jewish Hospital, Washinghton University in St Louis, St Louis, USA

Massimo Cristofanilli
, MD, FACP
Chief, Breast Medical Oncology
Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Scientific Director, the Englander Institute of Precision Medicine
Co-Leader, Meyer Cancer Center Management Team

Johann de Bono
,
Professor, Head of the Division of Clinical Studies, The Institute for Cancer Research, (ICR) and Royal Marsden, London, UK

Daniel De Carvalho
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada



Caroline Dive
, PhD
Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK

Daniel Haber, MD, PhD
Kurt J. Isselbacher Professor of Oncology, Medicine, Harvard Medical School, Director, MGH Cancer Center, Massachusetts General Hospital, Boston, USA

Helen Heitzer, PhD
Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria

Dave Hoon, PhD
Director Translational Molecular Medicine, SJCI PHS, Santa Monica CA, USA



Michail Ignatiadis, MD PhD
Assoc. Professor, Université Libre de Bruxelles, Jules Bordet Institute Brussels, Belgium, Chair Breast Cancer Group EORTC

Wolfgang Janni, MD PhD
Medical Director of the Gynaecological University Hospital Ulm, University of Ulm, Germany

Sabine Kasimir-Bauer, PhD
Professor, Head of Laboratory, Dep. of Gynecology and Obstetrics, University Hospital of Essen, Germany

Peter Kuhn
, PhD
Dean’s Professor of Biological Sciences and Professor of Medicine, Biomedical Engineering, and Aerospace & Mechanical Engineering, Associate Director of The Bridge@USC Los Angeles, CA, USA



Evi Lianidou
, PhD
Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece

Minetta C. Liu
, M.D.
Mayo Clinic, Rochester, Minnesota, USA

Mike Makrigiorgos
, PhD
Professor and Director, Medical Physics and Biophysics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA

Stuart S. Martin, PhD
Professor of Translational Cancer Research, University of Maryland School of Medicine, USA



Klaus Pantel, MD, PhD
Professor, Director, Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany

Nicholas Papadopoulos, PhD
Professor of Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA

Jean-Yves Pierga, MD, PhD
Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France

Amanda Psyrri
, MD, PhD
Professor, University of Athens Medical School, Attikon University Hospital, Athens, Greece



Christian Rolfo, MD, PhD, MBA, Dr.hc.
Professor and Assoc. Director for Clinical Research, Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York,  USA

Howard Scher
, MD
Medical Oncologist, Co-Chair, Center for Mechanism Based Therapy; Head of the Biomarker Development Initiative; D. Wayne Calloway Chair in Urologic Oncology, Memorial Sloan Kettering Cancer Research, New York, NY, USA

Gabriella Sozzi, PhD
Tumour Genomics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Michael Speicher
, MD
Institute of Human Genetics, Medical University of Graz, Austria



Nikolas Stoecklein, MD
Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany

Leon Terstappen
, MD, PhD
Professor, Faculty of Science and Technology, TechMed Centre, Department of Medical Cell BioPhysics, University of Twente, the Netherlands 

Andreas Trumpp
, PhD
 Head, Division of Stem Cells and Cancer at the German Cancer Research Center (DKFZ), Heidelberg, Germany